Mirum Pharmaceuticals Inc (NASDAQ:MIRM) Offers a High-Growth Momentum and Technical Breakout Setup

By – Last update:

Quotes Stocks Mentioned

Article Mentions:

For investors looking to join solid fundamental momentum with well-timed technical entry points, a layered screening method can be very useful. This tactic focuses on finding companies with solid and quickening earnings and sales growth, key traits of the high-growth momentum style, while also showing firm price trends and helpful chart patterns that indicate a possible breakout. By selecting for stocks with high marks in ChartMill's High Growth Momentum Rating, Technical Rating, and Setup Quality Rating, the aim is to locate securities where strong business momentum meets a positive technical situation, providing a combination of fundamental and technical health.

MIRM Stock Chart

Fundamental Growth Momentum

Mirum Pharmaceuticals Inc (NASDAQ:MIRM) shows a notable profile for investors focused on growth. The company's financial numbers display clear quickening, a main part of the High Growth Momentum Rating which looks at short-term earnings momentum, acceleration, and analyst outlook.

  • Earnings Acceleration: The year-over-year EPS growth for the latest quarter jumped to 116.7%, a clear quickening from the 76.9%, 44.4%, and 25.8% growth rates in the three prior quarters. This sequence of rising growth rates is a firm positive sign.
  • Sales Strength: Revenue growth stays solid, with the last quarter showing 47.2% year-over-year growth. This comes after a time of even higher growth rates, adding to a trailing twelve-month revenue rise of over 53%.
  • Positive Revisions and Surprises: Analyst outlook is positive, with the average EPS estimate for the next fiscal year adjusted higher by over 60% in the past three months. Also, the company has a solid history of surpassing forecasts, beating EPS estimates in three of the past four quarters by an average of 26.2%.
  • Cash Flow Generation: A key number is free cash flow, which increased by 142.7% over the last year and became positive on a per-share basis. This shows the company's growth is becoming actual cash generation, an important point for longevity.

These factors, accelerating earnings, firm sales, positive estimate changes, and cash flow turn, are exactly what the High Growth Momentum Rating aims to identify, making MIRM a stock that matches the outline of a company with strong short-term business momentum.

Technical Health and Setup Quality

Apart from the fundamentals, MIRM's price movement confirms a firm uptrend and shows a possible entry point. According to the detailed technical report, the stock receives a top Technical Rating of 10 out of 10. This score shows outstanding technical condition, supported by several points:

  • Firm Trends: Both the long-term and short-term trends are scored as positive.
  • Market Outperformance: The stock is doing better than 94% of the wider market over the past year and 84% of its biotechnology industry group. It is now trading close to its 52-week high.
  • Moving Average Backing: The stock price is above all main moving averages (20, 50, 100, and 200-day), and each of these averages is in a rising pattern, confirming the uptrend's health.

Importantly for timing an investment, the stock also has a Setup Quality Rating of 7. The analysis states that "prices have been consolidating lately and the volatility has been reduced," calling the current action a bull flag pattern. This pattern, which often appears after a firm rise, suggests the stock may be resting before a possible resumption of its uptrend. The report finds a clear support area between $96.72 and $98.23, giving a sensible zone for a stop-loss order to control risk.

A Merging Opportunity

The argument for MIRM is based on this merging. The company is not only growing; its growth is quickening, surpassing forecasts, and receiving upward analyst changes. This fundamental momentum is reflected in the stock's technical position, which displays a strong, maintained uptrend that is now taking a short pause as a consolidation. For investors using a high-growth momentum tactic, this pairing answers both the "what" to buy (a company with quick earnings momentum) and the "when" (during a technical situation that gives a specific risk point).

This screen is made to find more chances like this. For investors wanting to locate other stocks that fit these standards of high growth momentum paired with firm technical breakout situations, you can review the present results via this High Growth Momentum Breakout Setups Screen.


Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any securities. The information presented, including screens and ratings, is based on data believed to be reliable but is not guaranteed. All investing involves risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.